Dr. Andrew Renda’s work includes leading strategy, analytics, metrics and research related to measuring progress towards Humana’s Bold Goal of improving community health 20% by 2020. CDC’s Healthy Days survey instrument is used as the primary means of assessing population health. This is supported by clinical leading indicators and a robust research agenda that drives insights on how best to improve community health.
Previous roles have included advancing clinical models of care through development, implementation and evaluation of population health initiatives aimed at preventing and delaying progression of chronic disease. This included product and benefit design, as well as health projects ranging from messaging campaigns and self-care interventions to clinician-led disease management programs. Significant initiatives include: Chronic Condition Special Needs Plans (C-SNP), Metabolic Syndrome Support Service, Asthma and COPD disease management and self-care programs, Sleep Apnea diagnostics and management strategy, Flu and pneumonia campaign, Tobacco cessation service integration and outreach.
He also serves on several Humana clinical and research committees, including: Humana’s Clinical Leadership Network, Clinical Quality Metrics Alignment Governance Committee, Comprehensive Health Insights Joint Research Governance Committees, and Humana Publication Committee.
Dr. Renda has a B.S. in psychology and biology from the University of Kentucky where he was a National Science Foundation Undergraduate Fellow. He received his medical degree and a diploma in clinical psychiatry from the Royal College of Surgeons in Ireland, followed by a Master’s in Public Health from Harvard University.